News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
492,183 Results
Type
Article (26859)
Company Profile (169)
Press Release (465155)
Multimedia
Podcasts (30)
Webinars (7)
Section
Business (135408)
Career Advice (469)
Deals (22977)
Drug Delivery (45)
Drug Development (79914)
Employer Resources (46)
FDA (13177)
Job Trends (9771)
News (250064)
Policy (20600)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (3)
2024 BioMidwest Digital (3)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (7)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (3)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (9)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (2)
2026 Biotech Bay Standard (1)
Academia (1881)
Academic (1)
Accelerated approval (6)
Adcomms (27)
Allergies (80)
Alliances (38283)
ALS (93)
Alzheimer's disease (1364)
Antibody-drug conjugate (ADC) (124)
Approvals (13183)
Artificial intelligence (244)
Autoimmune disease (20)
Automation (12)
Bankruptcy (155)
Best Places to Work (8435)
BIOSECURE Act (17)
Biosimilars (69)
Biotechnology (133)
Bladder cancer (76)
Brain cancer (28)
Breast cancer (274)
Cancer (2187)
Cardiovascular disease (163)
Career advice (414)
Career pathing (14)
CAR-T (152)
Cell therapy (402)
Cervical cancer (20)
Clinical research (66223)
Collaboration (733)
Compensation (410)
Complete response letters (22)
COVID-19 (2123)
CRISPR (39)
C-suite (212)
Cystic fibrosis (93)
Data (2175)
Decentralized trials (2)
Denatured (16)
Depression (45)
Diabetes (228)
Diagnostics (5440)
Digital health (13)
Diversity (8)
Diversity, equity & inclusion (18)
Drug discovery (109)
Drug pricing (24)
Drug shortages (10)
Duchenne muscular dystrophy (83)
Earnings (50991)
Editorial (18)
Employer branding (4)
Employer resources (44)
Events (77023)
Executive appointments (612)
FDA (14311)
Featured Employer (28)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (662)
Gene editing (102)
Generative AI (24)
Gene therapy (275)
GLP-1 (536)
Government (2464)
Grass and pollen (4)
Guidances (41)
Healthcare (14143)
Huntington's disease (23)
IgA nephropathy (28)
Immunology and inflammation (105)
Indications (29)
Infectious disease (2238)
Inflammatory bowel disease (139)
Inflation Reduction Act (2)
Influenza (46)
Intellectual property (86)
Interviews (63)
IPO (11563)
IRA (8)
Job creations (1707)
Job search strategy (375)
Kidney cancer (11)
Labor market (18)
Layoffs (291)
Leadership (7)
Legal (3094)
Liver cancer (67)
Lung cancer (321)
Lymphoma (145)
Machine learning (5)
Management (14)
Manufacturing (209)
MASH (61)
Medical device (9712)
Medtech (9714)
Mergers & acquisitions (11924)
Metabolic disorders (541)
Multiple sclerosis (74)
NASH (14)
Neurodegenerative disease (94)
Neuropsychiatric disorders (21)
Neuroscience (1881)
NextGen: Class of 2025 (4035)
Non-profit (2522)
Northern California (2445)
Now hiring (20)
Obesity (258)
Opinion (147)
Ovarian cancer (71)
Pain (79)
Pancreatic cancer (80)
Parkinson's disease (150)
Partnered (14)
Patents (175)
Patient recruitment (109)
Peanut (43)
People (40328)
Pharmaceutical (37)
Pharmacy benefit managers (1)
Phase I (21254)
Phase II (29477)
Phase III (21422)
Pipeline (1091)
Policy (45)
Postmarket research (2117)
Preclinical (7807)
Press Release (45)
Prostate cancer (102)
Psychedelics (30)
Radiopharmaceuticals (249)
Rare diseases (355)
Real estate (3385)
Recruiting (16)
Regulatory (16828)
Reports (26)
Research institute (1961)
Resumes & cover letters (61)
Rett syndrome (5)
RNA editing (4)
RSV (26)
Schizophrenia (64)
Series A (124)
Series B (84)
Service/supplier (8)
Sickle cell disease (47)
Southern California (2084)
Special edition (12)
Spinal muscular atrophy (143)
Sponsored (17)
Startups (2646)
State (1)
Stomach cancer (12)
Supply chain (41)
Tariffs (5)
The Weekly (14)
United States (19449)
Vaccines (489)
Venture capitalists (25)
Weight loss (138)
Women's health (30)
Worklife (6)
Date
Today (118)
Last 7 days (729)
Last 30 days (2240)
Last 365 days (28496)
2025 (9080)
2024 (30364)
2023 (34421)
2022 (43476)
2021 (45640)
2020 (42134)
2019 (32466)
2018 (24412)
2017 (25401)
2016 (23366)
2015 (27360)
2014 (20085)
2013 (15620)
2012 (16389)
2011 (16946)
2010 (15954)
Location
Africa (417)
Alabama (45)
Alaska (4)
Arizona (133)
Arkansas (8)
Asia (36253)
Australia (6120)
California (5485)
Canada (1604)
China (501)
Colorado (227)
Connecticut (238)
Delaware (121)
Europe (69221)
Florida (719)
Georgia (172)
Idaho (39)
Illinois (337)
India (22)
Indiana (231)
Iowa (6)
Japan (145)
Kansas (81)
Kentucky (20)
Louisiana (7)
Maine (26)
Maryland (668)
Massachusetts (3956)
Michigan (138)
Minnesota (249)
Mississippi (1)
Missouri (58)
Montana (27)
Nebraska (21)
Nevada (49)
New Hampshire (52)
New Jersey (1438)
New Mexico (27)
New York (1508)
North Carolina (841)
North Dakota (8)
Northern California (2445)
Ohio (152)
Oklahoma (13)
Oregon (31)
Pennsylvania (1145)
Puerto Rico (8)
Rhode Island (17)
South America (555)
South Carolina (15)
Southern California (2084)
Tennessee (71)
Texas (815)
Utah (146)
Virginia (118)
Washington D.C. (41)
Washington State (484)
West Virginia (1)
Wisconsin (39)
492,183 Results for "clinical genomics pty ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia
April 2, 2025
·
5 min read
Press Releases
Halia Therapeutics Joins Forces with Southern Star Research Pty Ltd to Advance Clinical Development of Novel LRRK2 Inhibitor, HT-4253 for Neurodegenerative Diseases
September 3, 2024
·
4 min read
Press Releases
UK Company, Stablepharma Ltd, enters Phase 1 Clinical Trials with world-first Fridge-Free Tetanus & Diphtheria Vaccine
April 28, 2025
·
3 min read
Press Releases
Kairos Pharma, Ltd. Announces Data to be Presented at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
April 28, 2025
·
3 min read
Press Releases
Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd. for ~US$75 Million in a Share Exchange Transaction
Antev Shareholders to Receive Aggregate ~19% Equity Stake in Medicus, Plus US$65 Million in Contingent Payments
April 28, 2025
·
10 min read
BioCapital
Eilean Therapeutics Joins The Leukemia & Lymphoma Society’s Groundbreaking Beat AML® Master Clinical Trial
Eilean Therapeutics AU Pty Ltd has joined The Leukemia & Lymphoma Society in the groundbreaking collaborative Beat AML® Master Clinical Trial.
June 11, 2024
·
4 min read
Press Releases
Medicus Pharma Ltd Announces Positively Trending Interim Analysis for SKNJCT-003 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)
The Interim Analysis Showed Complete Clinical Clearance of More than Sixty (60%) Percent
March 6, 2025
·
6 min read
Press Releases
Kairos Pharma Ltd. Provides Letter to Stockholders
April 24, 2025
·
5 min read
Press Releases
Kairos Pharma Ltd. Announces Completed Enrollment of the Safety Arm of Its Phase 2 Clinical Trial of ENV105 in Metastatic, Castration-Resistant Prostate Cancer
April 1, 2025
·
4 min read
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
1 of 49,219
Next
